Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Compositional Optimization of Carboxymethyl Cellulose-Based Adhesive Hydrogels for Simultaneous Toughness Enhancement and Strong Interfacial Bonding.

Langmuir : the ACS journal of surfaces and colloids·2026

Same author

Pre-teriparatide anti-osteoporosis medication therapy and fracture-related hospitalization in patients at very high fracture risk.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026

Same author

Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026

Same author

Integrating Machine Learning into Fracture Liaison Services: Toward precision risk stratification in osteoporosis care: A prospective cohort study.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026

Same author

New insights in the chronic kidney disease-associated osteoarthritis progression: Role of uremic toxin indoxyl sulfate-induced chondrocyte senescence and ferroptosis.

Life sciences·2026

Same author

Glucagon-like peptide-1 receptor (GLP-1R) agonists prevent tributyltin-induced muscle atrophy/wasting via restoring GLP-1R signaling in vitro and in mice.

Ecotoxicology and environmental safety·2025

Same journal

Functional activities and immunohistochemical cellular distribution of glutathione s-transferases in normal, dysplastic, and squamous cell carcinoma human oral tissues.

Clinical medicine. Oncology·2011

Same journal

Psychological Distress among Prostate Cancer Patients: Fact Or Fiction?

Clinical medicine. Oncology·2011

Same journal

Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.

Clinical medicine. Oncology·2011

Same journal

Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna.

Clinical medicine. Oncology·2011

Same journal

Increased incidence of loco-regional recurrences among african american women with terminal stage breast cancer.

Clinical medicine. Oncology·2011

Same journal

Nef as a Proliferative Factor for Kidney Epithelial Cells in HIV-Associated Nephropathy.

Clinical medicine. Oncology·2011

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Thyroid carcinoma with bone metastases: a prognostic factor study.

Karl Wu¹, Shen-Mou Hou, Tien-Shang Huang

¹Department of Orthopedics, College of Medicine, National Taiwan University, National Taiwan University Hospital, Taipei, Taiwan.

Clinical Medicine. Oncology

|September 6, 2011

Summary

This summary is machine-generated.

Thyroid carcinoma can present with early bone metastases. Tumor type and hypercalcemia significantly impact survival, with papillary and follicular types showing better outcomes than anaplastic and medullary, and hypercalcemia worsening prognosis.

Keywords:

bone carcinoma metastasis prognosis thyroid

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Related Experiment Videos

Last Updated: May 29, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Area of Science:

Oncology
Endocrinology
Cancer Metastasis

Background:

Occult bone metastases from thyroid carcinoma often delay diagnosis and treatment.
Early detection is crucial for managing bone metastases in thyroid cancer patients.

Purpose of the Study:

To retrospectively investigate clinical outcomes of patients with thyroid carcinoma and bone metastases.
To analyze prognostic parameters influencing survival in these patients.

Main Methods:

Retrospective review of 44 patients with thyroid carcinoma and bone metastases (1993-2004).
Analysis of demographic data, metastasis location, histological type, treatments, and hypercalcemia.
Kaplan-Meier survival analysis and log-rank tests were used for statistical significance.

Main Results:

Bone metastasis incidence was 5.0%; papillary and follicular types were most common.
Hypercalcemia occurred in 12 patients. Mean survival post-metastasis was 5.3 years; 5-year survival was 79.4%.
Papillary and follicular thyroid cancers had significantly longer survival than anaplastic and medullary types (p < 0.05). Hypercalcemia was associated with worse survival (p < 0.05).

Conclusions:

Thyroid carcinoma can manifest with bone metastases early in its course.
Histological tumor type and the presence of hypercalcemia are significant prognostic factors for survival in patients with bone metastases.